Trials / Completed
CompletedNCT02356328
NovaTears® Eye Drops Observational Study NT-003
NovaTears® Observational Study NT-003
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Novaliq GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational study is intended to collect outcome data from a cohort of 30 patients suffering from dry eye disease due to chronic ocular Graft-versus-Host Disease (GvHD) who are treated with the medical device NovaTears® eye drops for a duration of 11 to 13 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NovaTears® Eye Drops | Topical eye drops for lubrication of the ocular surface |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2015-02-05
- Last updated
- 2016-03-09
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02356328. Inclusion in this directory is not an endorsement.